The use of biologic therapy in patients with RA and existing cancer.

被引：0
|
作者：
Wolfe, Frederick [1 ]
Michaud, Kaleb [1 ]
机构：
[1] Natl Data Bank Rheumat Dis, Wichita, KS USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S425 / S425
页数：1
相关论文
共 50 条
  • [1] Predictors of Mortality in RA Patients before Biologic Therapy
    Rosario, Debora Cordeiro
    Bulhoes, Camila Nobre
    Toledo, Rodrigo Peres
    Bonfiglioli, Karina
    Ribeiro, Ana C. M.
    Moraes, Julio C. B.
    Saad, Carla G. S.
    Silva, Clovis A.
    Bonfa, Eloisa
    Aikawa, Nadia E.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] TREATMENT WITH UPADACITINIB IN RA PATIENTS FOR WHICH BIOLOGIC THERAPY FAILED
    Kirkegard, L. Robles
    Romero, E. Rubio
    Leon, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 478 - 478
  • [3] PREDICTORS OF MORTALITY IN RA PATIENTS BEFORE THE ADVENT OF BIOLOGIC THERAPY
    Rosario, D. C.
    Bulhoes, C. N.
    Toledo, R. P.
    Bonglioli, K.
    Ribeiro, A. C. M.
    Moraes, J. C. B.
    Saad, C. G. S.
    Silva, C. A.
    Bonfa, E.
    Aikawa, N. E.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S84 - S85
  • [4] Is rituximab suitable for use as a first-line biologic therapy for RA?
    Kleiner, Anatole
    Looney, R. John
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (11): : 574 - 575
  • [5] Is rituximab suitable for use as a first-line biologic therapy for RA?
    Anatole Kleiner
    R John Looney
    Nature Clinical Practice Rheumatology, 2008, 4 : 574 - 575
  • [6] SAFETY OF SUBSEQUENT BIOLOGIC THERAPY IN RA PATIENTS WHO DISCONTINUED RITUXIMAB
    Genovese, Mark C.
    Breedveld, Ferdinand C.
    Emery, Paul
    Cohen, Stanley B.
    Keystone, Edward
    Matteson, Eric L.
    Burke, Laura
    Chai, Akiko
    Reiss, William
    Sweetser, Marianne
    Shaw, Tim
    RHEUMATOLOGY, 2011, 50 : 126 - 126
  • [7] EVALUATION OF BIOLOGIC THERAPY VERSUS TRIPLE DMARD THERAPY IN RA PATIENTS UNRESPONSIVE TO METHOTREXATE
    Vernice, Nicholas A.
    Reiss, Allison B.
    Renna, Heather A.
    DeLeon, Joshua
    Carsons, Steven
    Kasselman, Lora J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (03) : 697 - 697
  • [8] Thrombocytopaenia in RA leading to combined biologic therapy
    Moore, O.
    Liggett, N.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S571 - S571
  • [9] Disparities in the use of biologic therapies for the treatment of RA
    Berrios-Rivera, J. P.
    Johnson, M. L.
    Huston, D. P.
    Suarez-Almazor, M. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 275 - 275
  • [10] USE OF BIOLOGIC AGENTS IN THE QUEST-RA PATIENTS IN 3 NORDIC COUNTRIES
    Sokka, Tuulikki
    Hetland, Merete Lund
    Horsley-Petersen, Kim
    Hansen, Troels Mork
    Baecklund, Eva
    Flenrohn, Dan
    Oding, Rolf
    Liveborn, Margareth
    Luukkainen, Reijo
    Linmonen, Kai
    Pincus, Theodore
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2010, 39 : 35 - 35
12345